IRCT20220211053992N28RecruitingUnknown
In vivo fasted-state bioequivalence study of Amlodipine /Valsartan (10/ 60) tablet of Ronak pharmaceutical Co. compared to innovator product
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 59 years (—)
- Sex
- All
Inclusion Criteria
- •General Health (in terms of Liver, Heart and Kidney)
- •Age (18-59 years old)
Exclusion Criteria
- •History of cardiovascular, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
Investigators
Similar Trials
Recruiting
Unknown
Investigating bioequivalence of Amlodipine/Valsartan tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N12Tabriz University of Medical Sciences24
Recruiting
Unknown
Investigating the in vivo bioequivalence of Lamotrigine 100 mgIRCT20210519051345N41Tabriz University of Medical Sciences24
Not yet recruiting
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N32Tabriz University of Medical Sciences24
Not yet recruiting
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N34Tabriz University of Medical Sciences24
Not yet recruiting
Unknown
In vivo Bioequivalence study of Famotidine tabletIRCT20220211053992N35Tabriz University of Medical Sciences24